504 related articles for article (PubMed ID: 18292757)
1. Target organ damage in "white coat hypertension" and "masked hypertension".
Kotsis V; Stabouli S; Toumanidis S; Papamichael C; Lekakis J; Germanidis G; Hatzitolios A; Rizos Z; Sion M; Zakopoulos N
Am J Hypertens; 2008 Apr; 21(4):393-9. PubMed ID: 18292757
[TBL] [Abstract][Full Text] [Related]
2. White-coat and masked hypertension in children: association with target-organ damage.
Stabouli S; Kotsis V; Toumanidis S; Papamichael C; Constantopoulos A; Zakopoulos N
Pediatr Nephrol; 2005 Aug; 20(8):1151-5. PubMed ID: 15947982
[TBL] [Abstract][Full Text] [Related]
3. Assessment of target-organ damage in adolescent white-coat and sustained hypertensives.
Páll D; Juhász M; Lengyel S; Molnár C; Paragh G; Fülesdi B; Katona E
J Hypertens; 2010 Oct; 28(10):2139-44. PubMed ID: 20616755
[TBL] [Abstract][Full Text] [Related]
4. Subclinical arterial and cardiac damage in white-coat and masked hypertension.
Wojciechowska W; Stolarz-Skrzypek K; Olszanecka A; Klima Ł; Gąsowski J; Grodzicki T; Kawecka-Jaszcz K; Czarnecka D
Blood Press; 2016 Aug; 25(4):249-56. PubMed ID: 26953075
[TBL] [Abstract][Full Text] [Related]
5. Cardiac and arterial target organ damage in adults with elevated ambulatory and normal office blood pressure.
Liu JE; Roman MJ; Pini R; Schwartz JE; Pickering TG; Devereux RB
Ann Intern Med; 1999 Oct; 131(8):564-72. PubMed ID: 10523216
[TBL] [Abstract][Full Text] [Related]
6. Masked hypertension and target organ damage in treated hypertensive patients.
Tomiyama M; Horio T; Yoshii M; Takiuchi S; Kamide K; Nakamura S; Yoshihara F; Nakahama H; Inenaga T; Kawano Y
Am J Hypertens; 2006 Sep; 19(9):880-6. PubMed ID: 16942927
[TBL] [Abstract][Full Text] [Related]
7. Effects of childhood primary hypertension on carotid intima media thickness: a matched controlled study.
Lande MB; Carson NL; Roy J; Meagher CC
Hypertension; 2006 Jul; 48(1):40-4. PubMed ID: 16735644
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic criteria of white coat hypertension (WCH): consequences for the implications of WCH for target organs.
Pose-Reino A; Rodríguez-Fernández M; López-Barreiro L; Coleman IC; Estévez-Nuñez JC; Méndez-Naya I
Blood Press; 2002; 11(3):144-50. PubMed ID: 12126260
[TBL] [Abstract][Full Text] [Related]
9. White coat effect in treated and untreated patients with high office blood pressure. Relationship with pulse wave velocity and left ventricular mass index.
Silveira A; Mesquita A; Maldonado J; Silva JA; Polónia J
Rev Port Cardiol; 2002 May; 21(5):517-30. PubMed ID: 12174516
[TBL] [Abstract][Full Text] [Related]
10. White-coat hypertension, as defined by ambulatory blood pressure monitoring, and subclinical cardiac organ damage: a meta-analysis.
Cuspidi C; Rescaldani M; Tadic M; Sala C; Grassi G; Mancia G
J Hypertens; 2015 Jan; 33(1):24-32. PubMed ID: 25380162
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and clinical correlates of white coat hypertension in chronic kidney disease.
Minutolo R; Borrelli S; Scigliano R; Bellizzi V; Chiodini P; Cianciaruso B; Nappi F; Zamboli P; Conte G; De Nicola L
Nephrol Dial Transplant; 2007 Aug; 22(8):2217-23. PubMed ID: 17420167
[TBL] [Abstract][Full Text] [Related]
12. White-Coat and Reverse White-Coat Effects Correlate with 24-h Pulse Pressure and Systolic Blood Pressure Variability in Children and Young Adults.
Fujita H; Matsuoka S; Awazu M
Pediatr Cardiol; 2016 Feb; 37(2):345-52. PubMed ID: 26481222
[TBL] [Abstract][Full Text] [Related]
13. Relationship of ambulatory blood pressure and body mass index to left ventricular mass index in pediatric patients with casual hypertension.
Ramaswamy P; Chikkabyrappa S; Donda K; Osmolovsky M; Rojas M; Rafii D
J Am Soc Hypertens; 2016 Feb; 10(2):108-14. PubMed ID: 26725015
[TBL] [Abstract][Full Text] [Related]
14. Is there any real target organ damage associated with white-coat normotension?
Ormezzano O; Baguet JP; François P; Quesada JL; Pierre H; Mallion JM
Clin Auton Res; 2004 Jun; 14(3):160-6. PubMed ID: 15241644
[TBL] [Abstract][Full Text] [Related]
15. Target Organ Complications and Cardiovascular Events Associated With Masked Hypertension and White-Coat Hypertension: Analysis From the Dallas Heart Study.
Tientcheu D; Ayers C; Das SR; McGuire DK; de Lemos JA; Khera A; Kaplan N; Victor R; Vongpatanasin W
J Am Coll Cardiol; 2015 Nov; 66(20):2159-2169. PubMed ID: 26564592
[TBL] [Abstract][Full Text] [Related]
16. White coat effect and masked uncontrolled hypertension in treated hypertensive-diabetic patients: Prevalence and target organ damage.
Leiria LF; Severo MD; Ledur PS; Becker AD; Aguiar FM; Massierer D; Freitas VC; Schaan BD; Gus M
J Diabetes; 2015 Sep; 7(5):699-707. PubMed ID: 25327439
[TBL] [Abstract][Full Text] [Related]
17. Subclinical arterial damage in untreated masked hypertensive subjects detected by home blood pressure measurement.
Matsui Y; Eguchi K; Ishikawa J; Hoshide S; Shimada K; Kario K
Am J Hypertens; 2007 Apr; 20(4):385-91. PubMed ID: 17386344
[TBL] [Abstract][Full Text] [Related]
18. Ambulatory blood pressure measurement in the main cities of Cameroon: prevalence of masked and white coat hypertension, and influence of body mass index.
Takah N; Dzudie A; Ndjebet J; Wawo G; Kamdem F; Monkam Y; Luma H; Ngu KB; Kengne AP
Pan Afr Med J; 2014; 19():240. PubMed ID: 25848455
[TBL] [Abstract][Full Text] [Related]
19. White-coat hypertension: a selection bias? Harvest Study Investigators. Hypertension and Ambulatory Recording Venetia Study.
Palatini P; Dorigatti F; Roman E; Giovinazzo P; Piccolo D; De Venuto G; Mattarei M; Cozzutti E; Gregori S; Mormino P; Pessina AC
J Hypertens; 1998 Jul; 16(7):977-84. PubMed ID: 9794738
[TBL] [Abstract][Full Text] [Related]
20. Impact of the time rate of blood pressure variation on left ventricular mass.
Zakopoulos NA; Tsivgoulis G; Barlas G; Spengos K; Manios E; Ikonomidis I; Toumanidis S; Dolianitis K; Vemmos K; Vassilopoulos D; Moulopoulos SD
J Hypertens; 2006 Oct; 24(10):2071-7. PubMed ID: 16957568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
